§¥§à§Þ

§° Goldsite

§±§â§à§Õ§å§Ü§ä§í

§¬§Ý§Ú§ß§Ú§é§Ö§ã§Ü§Ú§Û §Ú§ß§ã§ä§â§å§Þ§Ö§ß§ä

§²§Ö§Ñ§Ô§Ö§ß§ä§í

§²§Ñ§ã§ç§à§Õ§ß§í§Û §Þ§Ñ§ä§Ö§â§Ú§Ñ§Ý

§£§Ö§ä§Ö§â§Ú§ß§Ñ§â§Ú§ñ

§¢§Ú§à§ä§Ö§ç§ß§à§Ý§à§Ô§Ú§é§Ö§ã§Ü§Ñ§ñ §Ñ§Ó§ä§à§Þ§Ñ§ä§Ú§Ù§Ñ§è§Ú§ñ

§²§Ö§ê§Ö§ß§Ú§ñ

§¯§à§Ó§à§ã§ä§Ú

§±§à§Õ§Õ§Ö§â§Ø§Ú§Ó§Ñ§ä§î

§³§Ü§Ñ§é§Ñ§ä§î

§³§Ó§ñ§Ù§Ñ§ä§î§ã§ñ §ã §ß§Ñ§Þ§Ú

P§å§ã§ã§Ü§Ú§Û
Français
Deutsch
???????
Português
Español
English
¼òÌåÖÐÎÄ

COVID-19 |SARS-CoV-2

§£§Þ§Ö§ã§ä§Ö §Þ§í §ã§Þ§à§Ø§Ö§Þ §ã §ï§ä§Ú§Þ §Ò§à§â§à§ä§î§ã§ñ

Goldsite §²§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§í§Ö §Ù§Ñ§Ò§à§Ý§Ö§Ó§Ñ§ß§Ú§ñ §¸§Ö§Ý§í§Ö §â§Ñ§ã§ä§Ó§à§â§í

§¢§í§ã§ä§â§í§Ö §Ú §ä§à§é§ß§í§Ö §â§Ö§Ù§å§Ý§î§ä§Ñ§ä§í §Õ§à§ã§ä§Ñ§Ó§Ü§Ú

COVID-19

COVID-19 ¡ª §ï§ä§à §Ù§Ñ§Ò§à§Ý§Ö§Ó§Ñ§ß§Ú§Ö, §Ó§í§Ù§í§Ó§Ñ§Ö§Þ§à§Ö SARS-CoV-2. COVID-19 §Þ§à§Ø§Ö§ä §Ò§í§ä§î §ä§ñ§Ø§Ö§Ý§í§Þ §Ú §ã§ä§Ñ§Ý §á§â§Ú§é§Ú§ß§à§Û §Þ§Ú§Ý§Ý§Ú§à§ß§à§Ó §ã§Þ§Ö§â§ä§Ö§Û §Ó§à §Ó§ã§Ö§Þ §Þ§Ú§â§Ö, §Ñ §ä§Ñ§Ü§Ø§Ö §Õ§Ý§Ú§ä§Ö§Ý§î§ß§í§ç §á§â§à§Ò§Ý§Ö§Þ §ã§à §Ù§Õ§à§â§à§Ó§î§Ö§Þ §å §ß§Ö§Ü§à§ä§à§â§í§ç, §Ü§ä§à §á§Ö§â§Ö§Ø§Ú§Ý §ï§ä§å §Ò§à§Ý§Ö§Ù§ß§î.§³§Ú§Þ§á§ä§à§Þ§í §á§à§ñ§Ó§Ý§ñ§ð§ä§ã§ñ §å §Ý§ð§Õ§Ö§Û §Ó §ä§Ö§é§Ö§ß§Ú§Ö 2¨C14 §Õ§ß§Ö§Û §á§à§ã§Ý§Ö §Ù§Ñ§â§Ñ§Ø§Ö§ß§Ú§ñ §Ó§Ú§â§å§ã§à§Þ.§¹§Ö§Ý§à§Ó§Ö§Ü, §Ú§ß§æ§Ú§è§Ú§â§à§Ó§Ñ§ß§ß§í§Û §Ü§à§â§à§ß§Ñ§Ó§Ú§â§å§ã§à§Þ, §Ù§Ñ§â§Ñ§Ù§Ö§ß §Õ§Ý§ñ §Õ§â§å§Ô§Ú§ç §Ó §ä§Ö§é§Ö§ß§Ú§Ö §Õ§Ó§å§ç §Õ§ß§Ö§Û §Õ§à §á§à§ñ§Ó§Ý§Ö§ß§Ú§ñ §ã§Ú§Þ§á§ä§à§Þ§à§Ó §Ú §à§ã§ä§Ñ§Ö§ä§ã§ñ §Ù§Ñ§â§Ñ§Ù§ß§í§Þ §Õ§Ý§ñ §Õ§â§å§Ô§Ú§ç §Ó §ä§Ö§é§Ö§ß§Ú§Ö 10¨C20 §Õ§ß§Ö§Û, §Ó §Ù§Ñ§Ó§Ú§ã§Ú§Þ§à§ã§ä§Ú §à§ä §Ö§Ô§à §Ú§Þ§Þ§å§ß§ß§à§Û §ã§Ú§ã§ä§Ö§Þ§í §Ú §ä§ñ§Ø§Ö§ã§ä§Ú §Ù§Ñ§Ò§à§Ý§Ö§Ó§Ñ§ß§Ú§ñ.§¬§à§â§à§ß§Ñ§Ó§Ú§â§å§ã §Þ§à§Ø§Ö§ä §á§Ö§â§Ö§Õ§Ñ§Ó§Ñ§ä§î§ã§ñ §à§ä §é§Ö§Ý§à§Ó§Ö§Ü§Ñ §Ü §é§Ö§Ý§à§Ó§Ö§Ü§å.§¦§Ô§à §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§â§å§ð§ä §ã §á§à§Þ§à§ë§î§ð §Ý§Ñ§Ò§à§â§Ñ§ä§à§â§ß§à§Ô§à §Ú§ã§ã§Ý§Ö§Õ§à§Ó§Ñ§ß§Ú§ñ.

Goldsite §°§Ò§Ù§à§â §ã§Ö§â§Ú§Ú §à COVID-19

§¬§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à

 
§±§à§Ü§Ñ§Ù§Ñ§ß§à:
¡ñ SARS-COV-2/§Ô§â§Ú§á§á A & B/RSV (4 §Ó §à§Õ§ß§à§Þ §Ü§à§Þ§Ò§à)
¡ñ SARS-COV-2/§Ô§â§Ú§á§á A & B/RSV/MP/ADV (6 §Ó §à§Õ§ß§à§Þ §Ü§à§Þ§Ò§à)
 
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 LGG/GM (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §ß§Ö§Û§ä§â§Ñ§Ý§Ú§Ù§å§ð§ë§Ú§ç §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
 

§ª§Þ§Þ§å§ß§à§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§è§Ú§ñ

¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 LGG/GM (§Ú§Þ§Þ§å§ß§à§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§è§Ú§ñ)
¡ñ §¯§Ñ§Ò§à§â §ß§Ö§Û§ä§â§Ñ§Ý§Ú§Ù§å§ð§ë§Ú§ç §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 (§Ú§Þ§Þ§å§ß§à§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§è§Ú§ñ)

§¥§Ý§ñ §á§â§à§æ§Ö§ã§ã§Ú§à§ß§Ñ§Ý§î§ß§à§Ô§à §Ú§ã§á§à§Ý§î§Ù§à§Ó§Ñ§ß§Ú§ñ

¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 LGG/GM (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 LGG/GM (§Ú§Þ§Þ§å§ß§à§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§è§Ú§ñ)
¡ñ §¯§Ñ§Ò§à§â §ß§Ö§Û§ä§â§Ñ§Ý§Ú§Ù§å§ð§ë§Ú§ç §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §ß§Ö§Û§ä§â§Ñ§Ý§Ú§Ù§å§ð§ë§Ú§ç §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 (§Ú§Þ§Þ§å§ß§à§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§è§Ú§ñ)

§¥§Ý§ñ §ã§Ñ§Þ§à§à§Ò§Ö§ã§á§Ö§é§Ö§ß§Ú§ñ

¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)

§¬§à§Ý§Ú§é§Ö§ã§ä§Ó§Ö§ß§ß§í§Û

¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 LGG/GM (§Ú§Þ§Þ§å§ß§à§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§è§Ú§ñ)
¡ñ §¯§Ñ§Ò§à§â §ß§Ö§Û§ä§â§Ñ§Ý§Ú§Ù§å§ð§ë§Ú§ç §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 (§Ú§Þ§Þ§å§ß§à§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§è§Ú§ñ)

§¬§Ñ§é§Ö§ã§ä§Ó§Ö§ß§ß§í§Û

¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 LGG/GM (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ §¯§Ñ§Ò§à§â §ß§Ö§Û§ä§â§Ñ§Ý§Ú§Ù§å§ð§ë§Ú§ç §Ñ§ß§ä§Ú§ä§Ö§Ý SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)

§®§à§Ý§Ö§Ü§å§Ý§ñ§â§ß§Ñ§ñ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ñ

¡ñ SARS-COV RT-PCR Kit
¡ñ §¯§Ñ§Ò§à§â §Ú§Ù §ï§Ü§ã§ä§â§Ñ§Ü§è§Ú§Ú §ß§å§Ü§Ý§Ö§Ú§ß§à§Ó§à§Û §Ü§Ú§ã§Ý§à§ä§í

§¬§à§Þ§Ò§à

¡ñ §¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ SARS-COV-2/§ã§Ö§Ù§à§ß§ß§í§Û §Ô§â§Ú§á§á (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à)
¡ñ SARS-COV-2/§Ô§â§Ú§á§á A & B/RSV (4 §Ó §à§Õ§ß§à§Þ §Ü§à§Þ§Ò§à)
¡ñ SARS-COV-2/§Ô§â§Ú§á§á A & B/RSV/MP/ADV (6 §Ó §à§Õ§ß§à§Þ §Ü§à§Þ§Ò§à)
§£§à §Ó§â§Ö§Þ§ñ §Ò§à§â§î§Ò§í §ã §á§Ñ§ß§Õ§Ö§Þ§Ú§Ö§Û COVID-19 Goldsite §Ò§í§ã§ä§â§à §â§Ö§Ñ§Ô§Ú§â§å§Ö§ä, §á§â§Ö§Õ§à§ã§ä§Ñ§Ó§Ý§ñ§ñ §Ü§à§Þ§á§Ý§Ö§Ü§ã§ß§à§Ö §Þ§Ö§ß§ð §ä§Ö§ã§ä§à§Ó §ß§Ñ COVID-19, §Ü§à§ä§à§â§à§Ö §Ó§Ü§Ý§ð§é§Ñ§Ö§ä §Ó §ã§Ö§Ò§ñ §Ñ§ß§ä§Ú§ä§Ö§Ý§Ñ §Ü SARS-CoV-2, §Ñ§ß§ä§Ú§Ô§Ö§ß, §ß§Ñ§Ò§à§â §Õ§Ý§ñ §à§Ò§ß§Ñ§â§å§Ø§Ö§ß§Ú§ñ §ß§å§Ü§Ý§Ö§Ú§ß§à§Ó§í§ç §Ü§Ú§ã§Ý§à§ä, §ã§â§Ö§Õ§å §Õ§Ý§ñ §ä§â§Ñ§ß§ã§á§à§â§ä§Ú§â§à§Ó§Ü§Ú §Ó§Ú§â§å§ã§Ñ §Ú §ä. §Õ. §¢§Ý§Ñ§Ô§à§Õ§Ñ§â§ñ §Þ§Ñ§â§Ü§Ú§â§à§Ó§Ü§Ö CE §ï§ä§à§Û §á§â§à§Õ§å§Ü§è§Ú§Ú §Ü§à§Þ§á§Ñ§ß§Ú§ñ Goldsite §ã§ä§Ñ§Ý§Ñ §à§Õ§ß§à§Û §Ú§Ù §á§Ö§â§Ó§í§ç §Ü§à§Þ§á§Ñ§ß§Ú§Û, §á§à§Ý§å§é§Ú§Ó§ê§Ú§ç §â§Ñ§Ù§â§Ö§ê§Ö§ß§Ú§Ö §ß§Ñ §ï§Ü§ã§á§à§â§ä.§±§â§à§Õ§å§Ü§ä§í, §ã§Ó§ñ§Ù§Ñ§ß§ß§í§Ö §ã COVID-19, §Ó §ß§Ñ§ã§ä§à§ñ§ë§Ö§Ö §Ó§â§Ö§Þ§ñ §á§â§à§Õ§Ñ§ð§ä§ã§ñ §Ò§à§Ý§Ö§Ö §é§Ö§Þ §Ó 20 §ã§ä§â§Ñ§ß§Ñ§ç §Ú §ç§à§â§à§ê§à §á§â§Ú§ß§Ú§Þ§Ñ§ð§ä§ã§ñ §ß§Ñ§ê§Ú§Þ§Ú §Ü§Ý§Ú§Ö§ß§ä§Ñ§Þ§Ú.§¢§Ý§Ñ§Ô§à§Õ§Ñ§â§ñ §ß§Ñ§Õ§Ö§Ø§ß§à§Þ§å §Ü§Ñ§é§Ö§ã§ä§Ó§å §ä§Ö§ã§ä §ß§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§í §á§à§Ý§å§é§Ú§Ý §ã§á§Ö§è§Ú§Ñ§Ý§î§ß§à§Ö §à§Õ§à§Ò§â§Ö§ß§Ú§Ö, §Ý§Ú§è§Ö§ß§Ù§Ú§ð §Ú§Ý§Ú §â§Ö§Ü§à§Þ§Ö§ß§Õ§à§Ó§Ñ§ß §Ü §á§â§à§Õ§Ñ§Ø§Ö §à§â§Ô§Ñ§ß§Ñ§Þ§Ú §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ §Ó§à §Þ§ß§à§Ô§Ú§ç §ã§ä§â§Ñ§ß§Ñ§ç, §Ó§Ü§Ý§ð§é§Ñ§ñ §¤§Ö§â§Þ§Ñ§ß§Ú§ð, §¶§â§Ñ§ß§è§Ú§ð, §¢§Ö§Ý§î§Ô§Ú§ð §Ú §ä. §Õ. §£§í§ã§à§Ü§Ñ§ñ §é§å§Ó§ã§ä§Ó§Ú§ä§Ö§Ý§î§ß§à§ã§ä§î §Ú §ã§á§Ö§è§Ú§æ§Ú§é§ß§à§ã§ä§î §á§â§à§Õ§å§Ü§ä§Ñ §ä§Ñ§Ü§Ø§Ö §á§à§Ù§Ó§à§Ý§ñ§ð§ä §Ö§Þ§å §á§â§à§Û§ä§Ú §°§è§Ö§ß§Ü§Ñ §ä§â§Ö§ä§î§Ö§Û §ã§ä§à§â§à§ß§í, §á§â§à§Ó§Ö§Õ§Ö§ß§ß§Ñ§ñ PEI §Ú §°§Ü§ã§æ§à§â§Õ§ã§Ü§Ú§Þ §å§ß§Ú§Ó§Ö§â§ã§Ú§ä§Ö§ä§à§Þ, §Õ§à§Ò§Ñ§Ó§Ý§ñ§Ö§ä §ä§Ö§ã§ä §Ó §à§Ò§ë§Ú§Û §ã§á§Ú§ã§à§Ü §¦§³ §Ò§í§ã§ä§â§í§ç §ä§Ö§ã§ä§à§Ó §ß§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§í, §â§Ö§Ù§å§Ý§î§ä§Ñ§ä§í §Ü§à§ä§à§â§í§ç §Ô§à§ã§å§Õ§Ñ§â§ã§ä§Ó§Ñ-§é§Ý§Ö§ß§í §Ó§Ù§Ñ§Ú§Þ§ß§à §á§â§Ú§Ù§ß§Ñ§ð§ä §Õ§Ý§ñ §Þ§Ö§â §à§Ò§ë§Ö§ã§ä§Ó§Ö§ß§ß§à§Ô§à §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ.Goldsite §¬§à§Þ§á§Ý§Ö§Ü§ã§ß§í§Ö §â§Ö§ê§Ö§ß§Ú§ñ §Õ§Ý§ñ §Ò§à§â§î§Ò§í §ã COVID-19 §à§ç§Ó§Ñ§ä§í§Ó§Ñ§ð§ä RT-PCR, §Ñ§ß§ä§Ú§ä§Ö§Ý§Ñ §Ú §Ñ§ß§ä§Ú§Ô§Ö§ß§í, §à§ä §á§â§à§æ§Ö§ã§ã§Ú§à§ß§Ñ§Ý§î§ß§à§Ô§à §Ú§ã§á§à§Ý§î§Ù§à§Ó§Ñ§ß§Ú§ñ §Õ§à §ã§Ñ§Þ§à§ã§ä§à§ñ§ä§Ö§Ý§î§ß§à§Ô§à §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ.

§±§²§ª§­§°§¨§¦§¯§ª§¦

§³§¸§¦§¯§¡§²§ª§ª

Goldsite Diagnostics Inc., §à§ã§ß§à§Ó§Ñ§ß§ß§Ñ§ñ §Ó 1999 §Ô§à§Õ§å, §ñ§Ó§Ý§ñ§Ö§ä§ã§ñ §Ó§Ö§Õ§å§ë§Ú§Þ §Ü§Ú§ä§Ñ§Û§ã§Ü§Ú§Þ §á§â§à§Ú§Ù§Ó§à§Õ§Ú§ä§Ö§Ý§Ö§Þ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§é§Ö§ã§Ü§Ú§ç §ã§â§Ö§Õ§ã§ä§Ó, §ã§á§Ö§è§Ú§Ñ§Ý§Ú§Ù§Ú§â§å§ð§ë§Ú§Þ§ã§ñ §ß§Ñ §å§ã§ä§â§à§Û§ã§ä§Ó§Ñ§ç §Ú §â§Ö§Ñ§Ô§Ö§ß§ä§Ñ§ç §Õ§Ý§ñ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ú in vitro.

§³§Ó§ñ§Ù§Ñ§ä§î§ã§ñ

? (+86)-755-26890807

    (+86)-755-26897973
? export@

 

Copyright © 1999¨C2023 Goldsite Diagnostics Inc., §£§ã§Ö §á§â§Ñ§Ó§Ñ §Ù§Ñ§ë§Ú§ë§Ö§ß§í. Sitemap